Table 4.
Regimen | Diagnosis | CD34 + cell yield (× 106) | Collection Failure (%) | N |
---|---|---|---|---|
GCSF + BED (current study) | MM | 21.60 | 0 | 34 |
GCSF + CY27 | MM | 10.3 | NR | 370 |
GCSF + CY43 | MM | 14.2 | 0 | 19 |
GCSF + VP-1644 | MM | 12 | 0 | 152 |
GCSF + VP-1645 | Lymphoma | 6.2 | 6 | 159 |
GCSF + CY46 | Lymphoma | 7.2 | 4.2 | 24 |
GCSF + CY47 | MM | 33.4 | 18 | 22 |
GCSF + CY48 | NHL | 6.41 | NR | 12 |
GCSF + CY49 | MM | 4.65 | 0 | 37 |
GCSF + CY50 | NHL | 7.1 | 10.5 | 34 |
GCSF + CY43 | MM | 16 | NR | 34 |
GCSF + CY + VP-1651 | MM | 22.5 | 4 | 49 |
GCSF + CY52 | MM | 5.9 | 4 | 51 |
GSCF + CY53 | MM | 8.6 | 0 | 15 |